Abstract
Chaperonin containing tailless complex polypeptide 1 (CCT) or tailless complex polypeptide 1 ring complex (TRiC) is an essential eukaryotic molecular chaperone. It is a multi-subunit oligomer of two rings of eight individual protein subunits. When assembled, each of the eight CCT subunits occupies a specific position within each chaperonin ring. Thus a geometrically defined binding interface is formed from the divergent sequences within the CCT subunit substrate binding domains. CCT is required for the folding of the abundant cytoskeletal proteins actin and tubulin, which in turn form assemblies of microfilaments and microtubules. CCT is also involved in the folding of some additional protein substrates and some CCT subunits have been shown to have functions when monomeric. Since observations were made in worms over a decade ago using an RNAi screen, which connected CCT subunits to the aggregation of polyglutamine tracts, a role for CCT as a potential modulator of protein aggregation has started to emerge. Here there will be a focus on how mechanistically CCT may be able to achieve this and if this potential function of CCT provides any insights and directions for developing future treatments for protein aggregation driven neurodegenerative diseases generally, many of which are associated with aging.
Highlights
The maintenance of proteostasis is paramount to cellular health
The potential of CCT1(α) to be therapeutically active was examined by Sontag et al (2013) where yeast CCT1(α) apical domain was applied to PC12 cells and striatal cells derived from a mouse knock in both expressing aggregating model versions of the huntingtin protein
The oligomeric containing tailless complex polypeptide 1 (CCT) will play an essential role in proteostasis by mediating the folding of its obligate substrates and an array of lower abundance proteins
Summary
The maintenance of proteostasis is paramount to cellular health. Numerous events contribute to proteostasis, such as transcription/translation and proteolysis, to ensure that protein levels are optimal. If cells become deficient in their chaperoning capacity during aging or if proteostasis is disrupted as a consequence of protein misfolding diseases, modulation of chaperone activity may provide a mechanism to combat the formation of potentially
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have